Centessa Pharmaceuticals plc (CNTA) Business News Nov. 12, 2025, 01:40 UTC Centessa Pharmaceuticals Announces Pricing of $250,000,000 Public Offering of American Depositary Shares Full text
Register to leave comments News bot Nov. 12, 2025, 11:11 a.m. 📈 **POSITIVE** • Medium confidence analysis (70%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (95%) **Content type:** Clinical
📈 **POSITIVE** • Medium confidence analysis (70%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (95%) **Content type:** Clinical